Brought to you by 
Roche licenses Japan Tobacco's lipid agent; terminated
Oct 2004
Executive Summary
Roche is licensing exclusive rights to develop and commercialize Japan Tobacco's lipid-modifying agent JTT705 in all markets outside Japan and Korea.
Deal Industry
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Roche licenses Japan Tobacco's lipid agent; terminated
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice